Included in the formulation
АТХ:P.02.C.X.01 Pirvinium
Pharmacodynamics:The pharmacological action is anthelmintic. The pyrvinium embonate is active against Enterobius vermicularis. The mechanism of action is associated with the blockade of helminth enzyme systems. Highly effective at a single admission.
Pharmacokinetics:Not described.
Indications:Enterobiosis.
I.B65-B83.B80 Enterobiosis
Contraindications:Inflammatory bowel disease, impaired gastric emptying, children under 3 months of age, hypersensitivity to embryo pervinia.
Pregnancy and lactation:No data. Do not apply.
Dosing and Administration:Establish in view of the age and body weight of the patient. When enterobiosis, children 3 months (5 kg or more) - 2.5 ml (15 mg / ml) of suspension, 1-2 years (10 kg and more) - 5 ml, 3-4 years (15 kg and more) - 7.5 ml, 5-6 years (20 kg and more) - 10 ml, 7-8 years (25 kg and more) - 12.5 ml, 9-10 years (30 kg and more) - 15 ml, 11-12 years (35 kg and more) - 17.5 ml, 13-14 years (40 kg and more) - 20 ml, 14-15 years (50 kg and more) - 25 ml. Adults with a body weight of more than 80 kg - no more than 400 mg or 40 ml of suspension.
Is taken orally once in a dose of 5 mg / kg 2-3 hours after eating (or immediately after a light breakfast), washed down with water, tea or fruit juice. Before use should be shaken.
If necessary, the reception can be repeated after 2 weeks.
Side effects:Rarely: nausea, vomiting, diarrhea, allergic reactions (in particular, skin rash), photodermatosis.
Overdose:Not described. Treatment is symptomatic.
Interaction:During treatment, no special diet or laxatives are required.
Special instructions:Treat all members of the family or the entire children's team. With positive control tests, it is recommended to repeat the course after 6-8 weeks. Stains feces in red.
In case of occurrence of such side effects as diarrhea or vomiting when taking embryate burial, it is necessary to reuse it to provide an adequate anthelmintic effect.